Xeris Pharmaceuticals (2B30) Cash flow

0 Followers

Xeris Pharmaceuticals Cash Flow

DE:2B30's free cash flow for Q2 2026 was $8.05M. For the 2026 fiscal year, DE:2B30's free cash flow was decreased by $65.78M and operating cash flow was $8.26M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ 28.63M	$ -36.98M	$ -47.02M	$ -102.89M	$ -95.53M
Investing Cash Flow	$ -696.00K	$ 4.88M	$ -6.00M	$ 34.46M	$ 97.96M
Financing Cash Flow	$ 11.39M	$ 36.17M	$ -1.61M	$ 127.47M	$ 27.25M
End Cash Position	$ 115.06M	$ 75.74M	$ 71.67M	$ 126.31M	$ 67.27M
Free Cash Flow	$ 27.93M	$ -37.85M	$ -49.29M	$ -103.42M	$ -96.62M

Currency in USD